期刊
FRONTIERS IN IMMUNOLOGY
卷 12, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.808064
关键词
maternal immunization; pregnant women; SARS-CoV-2; COVID-19; maternal vaccination program
类别
资金
- World Association
Pregnant women infected with SARS-CoV-2 are at a higher risk of severe illness and death compared to non-pregnant women of childbearing age. Many countries recommend COVID-19 vaccination for pregnant women, and recent studies have provided preliminary evidence supporting the safety and efficacy of this practice. Further research is needed to address knowledge gaps and optimize protection for pregnant women and their infants.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据